Regeneron shared new findings from its Phase 2 PINNACLE trial of baloncibart for POTS.

REGN · Regeneron Pharmaceuticals, Inc.

The AI's read

The drug is still described as investigational. The story says the study tested its benefit and safety, but gives no findings about either. Without those details, readers cannot tell whether baloncibart helped patients or raised safety concerns.